Skip to main content
PRLDPrelude Therapeutics IncorporatHold5.1·$3.83
PRLD · Decision

Should you buy Prelude Therapeutics Incorporat (PRLD)?

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
HOLD
Score
5.1/10
Price
$3.83
Entry / Take Profit (TP) / Stop Loss (SL)
/ $6.80 / $3.66

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

  • Sub Scale Market Cap Not InvestableImproving
  • Strong Insider Buying SignalDeteriorating
  • Earnings Catalyst With Beat StreakStable
  • +2 more pillars — see the Why tab for full reasoning

→ Full pillar scorecard with all 5 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Sub Scale Market Cap Not Investable

    Trip ifMarket capitalization stays below $300M for 2 consecutive quarters, moving further from rather than toward the $400M threshold.

  • P2Strong Insider Buying Signal

    Trip ifNet insider selling exceeds 1,000,000 shares over the next 90 days, reversing the current +7,882,882 share buying signal.

  • P3Earnings Catalyst With Beat Streak

    Trip ifThe company posts at least 2 consecutive quarterly misses, breaking the current 3-of-4 beat streak.

  • P4Severe Cash BurnTripped

    Trip ifFree cash flow drops below -150% of revenue, deepening the burn rate from the current -107%.

  • P5Wide Analyst Target GapTripped

    Trip ifThe analyst target gap compresses below 20% from the current 61.9%, without meaningful price appreciation.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Prelude Therapeutics Incorporat (PRLD) is HOLD_IF_HOLDING with medium conviction, score 5.1/10 at $3.83. Bull and bear cases are roughly balanced; the engine output is HOLD because neither side cleared a positive-conviction threshold.

2. What the engine sees

On the bear side: Concentration risk — Supplier: single source suppliers; Market cap $313M below $400M minimum. Active engine warnings: Market cap $313M below $400M minimum, V9 Gate Failed: MOMENTUM:3.2<4.5.

3. Entry, target, and stop

The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around with a technical stop near $3.66 for existing positions. Asymmetric R:R is 5.17, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

4. What would change the verdict

HOLD flips toward BUY_WAIT if momentum at 3.2 vs threshold 4.5 clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates PRLD — 10-dimension breakdown →

Bear case

  • Concentration risk — Supplier: single source suppliers
  • Market cap $313M below $400M minimum
Home Stocks PRLD Buy or sell?